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The medical application of nanomaterials is growing fast. Amongst the most widely used, silver 
nanoparticles are antimicrobial agents whose key application is the care of burns and chronic 
wounds. Still, their absorption, distribution, metabolism and excretion behaviour in vivo has not 
yet been systematically investigated. We collected full-profile specimens of skin from four hospital 
patients with mid-to-deep thickness burns or equivalent skin wounds, treated with dressings 
containing silver nanoparticles or silver sulfadiazine. Synchrotron radiation µXRF/µXANES and 
laser ablation-ICP-MS were used to provide the first semi-quantitative/high resolution direct 
information on the spatiotemporal distribution and speciation of silver in vivo. The metal was 
rapidly released onto the wound surface, followed by a significant structure-dependent 
penetration into the damaged tissues. This was accompanied by sequential processes of metallic 
silver dissolution, chloride complexation, change to metal-thiol protein complexes, and final 
mobilization into deeper skin layers towards the vascular networks. Complete local clearance of 
silver was observed after 12 days of treatment in the case of full healing. The results provide a 
complete insight into the dynamics of silver in real human wounds, and a new basis for the design 
of innovative silver nanomaterials with optimal antibacterial efficacy and minimized risk for the 
patient.
















































































































List of the acronyms
Ag silver
BSA bovine serum albumin
DLS dynamic light scattering
ECM extracellular matrix
ELS electrophoretic light scattering
ESRF European Synchrotron Radiation Facility
GSH glutathione
HINS human insulin
HSA human serum albumin
HSS human serum substitute
HTF human transferrin 
LA-ICP-MS laser ablation-inductively coupled plasma-mass spectrometry
LCF linear combination fitting





ROS reactive oxygen species
SEM-EDX scanning electron microscopy - energy dispersive X-ray spectroscopy
SR-µXANES synchrotron radiation X-ray absorption near edge structure
SR-µXRF synchrotron radiation micro x-ray fluorescence

















































































































Burn injuries are a critical care problem of high concern for public health. Severe burns may be 
life threatening due to extensive loss of plasma, specific and systemic immunological response, 
bacterial infections and septicemia.1 The management of wound bed in burns requires dedicated 
treatment protocols, different from all the other types of wound, whose quality is fundamental 
for stabilizing the patient, preventing the infection and optimizing tissue regeneration, but also 
for the long-term metabolic, functional and esthetical recovery.2 
Silver (Ag) has been used since ancient times in the treatment of burns and chronic skin lesions 
due to its observational efficacy in promoting tissue repair. Only over the last century the specific 
capacity of Ag to inhibit microbial growth were elucidated and systematically exploited in clinical 
settings to protect the wound against infection, a critical complication which can slow down or 
even prevent, the spontaneous regeneration of damaged tissues.3 The metal is now well known 
as an effective multispectral antibacterial, antiseptic, and anti-inflammatory agent. Its 
antimicrobial action unfolds through multiple pathways, resulting in limited onset of bacterial 
resistance and effectively preventing biofilm formation.4–7 The bioactive species of the metal is 
the Ag+ ion, which binds to the cell wall of bacteria and deactivates many enzymes vital for their 
metabolism. However, the ion is also prone to rapid inactivation by binding to chloride or 
biomolecules in the wound microenvironment.8,9 This makes local application the only effective 
treatment with Ag as this ensures sustained concentrations of its ionic form on the surface layer 
of the wound bed. Indeed, medications containing Ag(I) species, such as Ag nitrate solutions and 
Ag sulfadiazine creams (widely used for the emergency treatment of burns) require multiple daily 
applications to remain effective.10 Great efforts are currently underway to develop innovative 
materials that ensure an effective and modulated antibacterial action of Ag, with concomitant 
minimum dosage, preserved hydration, mediated cells transferring to the wound, and general 
comfort for the patient. A new generation of Ag-based dressings have been designed, consisting 
of biocompatible scaffolds (meshes, foams, gels or composites) impregnated with Ag as soluble 
salts, AgCl, microcristalline Ag sulfadiazine, or as a metallic film.11,12 One of the most promising 
approaches bases on metallic Ag nanoparticles (AgNPs).13 The nanoparticulate forms of Ag exhibit 
unique physico-chemical properties such as nanometric size, crystal structures and enhanced 
surface reactivity, which can be specifically designed for an improved stability in biological 
media,10,14 enhanced affinity for cellular membranes to favour the uptake, and calibrated 
dissolution for delivery of the ion to intracellular targets.6,15,16 Several new dressings with AgNPs 
have been developed over the last years and tested in vitro for their antibacterial efficacy, 
including functionalized nanofibers,17 impregnated hydrogels,18 and doped bio-nano composite 
foams and films.19 An extensive review of these materials has been published recently.20 A 
growing body of evidence supports the clinical effectiveness of the few dressing loaded with 
AgNPs that are already being employed in hospitals,21–25 and the medical use of AgNPs is therefore 
expected to expand rapidly in the near future.
However, great concern remains in the scientific community regarding the safety implications of 
the administration of AgNPs to humans,26 because the moderate cytotoxicity of Ag+ towards skin 
















































































































cells is also well documented,10,27,28 and contradictory effects on wound re-epithelialisation have 
been reported after use of Ag-containing dressings.21,22 It is now generally accepted that AgNPs 
do not exert any specific toxic action,14,21,29 but as they carry out a modulated delivery of Ag+, 
toxicity through indirect mechanisms is supposed. Particularly, endocytic uptake of AgNPs leads 
to direct delivery of Ag+ ions to the intracellular environment, where they interact with thiol 
groups of mitochondrial membrane proteins, causing a cascade of cellular dysfunctions mediated 
by  reactive oxygen species (ROS) generation.28 Alteration of DNA and chromosomal breakage has 
been also reported, in association with AgNPs penetration into the nucleus.28 As observed for 
antibacterial efficacy, these toxic effects are size- and shape-dependent because AgNPs 
morphology impacts their penetration ability and surface reactivity.30
Designing materials and defining usage protocols to achieve optimal in vivo efficacy with a 
minimum dosage and risk for the patient requires a detailed knowledge of the dynamics of Ag in 
the human body. This knowledge is currently incomplete.
The chemical behaviour of AgNPs in the wound can be inferred from theoretical models and from 
limited experiments on dissolution, administration to cell cultures and percutaneous permeation 
carried out in vitro or ex vivo. Most studies indicate that although absorption of the metal through 
intact skin may be exceedingly low,22,23,31,32 damage to the skin barrier as happens in a wound 
could significantly favour penetration.33,34 A positive correlation between blood Ag level and 
wound extent or severity observed in patients treated with AgNPs supports this theory.23,24,35,36
Still, it remains unclear whether Ag is mobilized as active pristine NPs, or as deactivated 
biocomplexes of the ionic form. This issue is the key for predicting the local and systemic activity 
of the absorbed metal. Simplified in vitro experiments suggest several possibilities for biochemical 
processes involving AgNPs in situ, including: oxidative dissolution,9,27,37 surface interaction with 
biomolecules and exchange of free Ag+ ions,9,37 as well as photoreductive generation of secondary 
nanoparticulate species.8,34 However, direct observations describing how these processes interact 
in time and space in vivo have not been provided so far. In vivo rodent burn models are limitedly 
reliable because their wounds heal following different mechanisms, and do not exude fluids as 
human lesions do.38,39 Pigs are the best choice for preclinical evaluations,38 but only a few data 
are available on the total deposition of Ag in the scar of a porcine burn model so far.40
This study provides the first direct observation of the spatiotemporal distribution and chemical 
transformations of Ag in the wounds of four real patients (A-D), who underwent clinical treatment 
with a commercial dressing containing AgNPs, namely Acticoat Flex3TM. Full-profile biopsy 
samples were collected from the wound beds at different time steps from admission to complete 
healing. They were analysed by the high resolution elemental imaging methods of synchrotron 
radiation micro x-ray fluorescence (SR-µXRF) and laser ablation-inductively coupled plasma-mass 
spectrometry (LA-ICP-MS), and the chemical speciation of Ag was determined by synchrotron 
radiation X-ray absorption near edge structure (SR-µXANES) analysis. The results show how Ag 
nanoparticles and ions interact with bioligands while migrating within the skin wound, as a 
function of its structural damage and healing progression.

















































































































An extended version of this methods section can be found in Supplementary Information, 
inclusive of additional details on the experimental conditions and approaches, and a comparison 
of the analytical performances of SR-µXRF and LA-ICP-MS. 
2.1 Characterization of the dressing and release of Ag in vitro
Extensive physico-chemical characterization of Acticoat Flex3TM and in vitro release experiments 
of Ag and AgNPs from the product have been carried out in previous works.22,41–43 Additional 
analyses performed in this study included the determination of pH-dependent colloidal stability 
and size distribution of primary NPs released from the dressing in water, and the identification of 
Ag-binding proteins in a synthetic serum substitute as the release medium. Fragments of the 
intact dressing (130 mg) were placed into 6 mL of ultrapure water at pH adjusted to 5, 6 and 7 
(using NaOH), and then sonicated for 16 min at 37% amplitude in an ice bath using a Q700 device 
(Qsonica, Newtown, CT, USA), equipped with microtip probe. The suspensions were centrifuged 
at 120 g for 10 min to settle major debris, and the supernatants were analysed to determine the 
ζ-potential by electrophoretic light scattering (ELS), and the size distribution by dynamic light 
scattering (DLS), using a Zetasizer Nano ZS system (Malvern Panalytical, Malvern, UK). For the 
identification of Ag-binding proteins in human serum substitute (HSS, from Steamcell 
Technologies, Vancouver, Canada), release experiments were carried out as reported previously.42 
After 72h of incubation with the dressing, 0.5 mL of HSS were purified from non-protein species 
and concentrated using a 3kDa cut-off centrifugal filter (Microcon Merck Millipore, Milan, Italy). 
Five µL of the solution recovered from the filter were diluted 100-fold in trifluoroacetic acid 0.1% 
vol. solution (in H2O/acetonitrile 1:1 vol.), then 1 µL of the mix was deposited onto the appropriate 
sample holder and let dry. Analysis by matrix-assisted laser desorption time-of-flight mass 
spectrometry (MALDI-TOF-MS) was performed using an instrument Ultraflex II (Bruker Daltonics, 
Bremen, Germany) with pulsed UV laser beam (nitrogen laser, 337 nm) and operating in linear 
positive ion mode. External mass calibration was performed using the Protein Calibration 
Standard II (Bruker Daltonics), based on the average values of [M+H]+ of trypsinogen, protein A, 
bovine serum albumin (BSA) and the average values of [M+2H]2+ of protein A and BSA.
2.2 Patients recruitment
The study was carried upon approval by the Ethics Committee for Clinical Practice of the University 
Hospital of Padua (Prot. 28289/2016), and in accordance with the Declaration of Helsinki ethical 
guidelines, practice guidelines, and local laws and regulations. Informed written consent was 
obtained from all participants. The study involved four patients (A-D) providing skin samples 
through the bio-bank of the University Hospital of Padua. Patients were eligible for the study if 
affected by partial or full thickness burn or equivalent wound. All patients were treated at the 
Burns Centre of the Hospital, by using the same type of AgNPs-containing dressing as reported 
elsewhere,22 and following current protocols without any additional invasive procedure. Beside 
eligibility criteria, patients were selected so to be representative of different protocols used for 
wound treatment, and distinct healing progressions, outlined below. Given the intrinsic 
















































































































constrains, a relatively low number of patients and samples were selected for the analyses, and 
therefore must be considered within the specificity of their respective case-study.
Patient A (male, age 63) had partial thickness bilateral burn on the legs and hands, due to 
backfiring in an open environment. Biopsies were performed on deep partial thickness wound 
regions of the right leg. The first sample was collected after surgical cleaning of the wound and 
before a single application of the dressing, which was kept on site after complete healing. Further 
biopsies were performed at 3, 6, 9 and 12 days of treatment, corresponding to complete healing, 
from regions of interests at the wound margins above the dressing. Patient B (male, age 54) was 
affected by a degloving injury of the left leg, equivalent to a full thickness burn lesion. The first 
sample was collected after surgical cleaning of the wound and before application of the dressing. 
At 4, 7 and 10 days of treatment (complete healing) the dressing was changed, and biopsies were 
performed contextually. Patient C (female, age 56) had a full thickness flame burn to the thorax. 
The first sample was collected from the left axilla after surgical cleaning and before application of 
the dressing. Two additional biopsies were performed on the same area after 7 and 15 days of 
treatment in correspondence with dressing changes. At last sampling time, wound healing was 
still incomplete. Patient D (male, age 48) had a partial thickness flame burn to both legs and 
arrived in the Burns Centre after emergency treatment with Ag sulfadiazine 1% cream in another 
hospital. The first biopsy was performed on the medial region of the right leg, after application of 
the cream and before surgical cleaning, and a second biopsy after 5 days of treatment with a single 
application of the dressing, when skin regeneration was still incomplete.
2.3 Biopsy samples collection and preparation
Full-thickness biopsy samples of the wounds were collected using a surgical punch of 4 mm i.d. 
and 7 mm of length. The samples were immediately frozen at -80°C  without any preserving or 
fixing agent. Despite this approach could induce minor morphological artifacts in the tissue due 
to the growth of ice crystals,44 undetected in the histological analysis of these samples, it was 
selected as the most reliable to maintain the distribution and speciation of Ag.45 Based on 
preliminary analyses, specific patients and samples were selected to be dedicated to semi-
quantitative imaging or speciation analysis with optimized respective preparation procedures, in 
order to maximize the probability to extract useful and representative results. For LA-ICP-MS 
analysis, the samples were cryosectioned longitudinally into 20 μm thick slices. The sections were 
deposited onto uncoated microscope glass slides and dried at room temperature overnight. The 
residual unsliced portion of the samples from patient B was used for quantitative Ag 
determination by bulk ICP-MS analysis (see below). For SR-µXRF and SR-µXANES analyses, the 
samples were cryosectioned into slices of 30 μm of thickness, placed between Ultralene covered 
microscopy slices, and freeze-dried overnight. Histological images were obtained for slices 
(thickness 20 µm, ethanol stain followed by toluidine blue stain) adjacent to those that were 
analysed for elemental mapping and speciation.
2.4 Synchrotron radiation μXRF and μXANES
















































































































High-resolution imaging of Ag distribution and single-point speciation of the metal in the skin 
profiles of patient A were determined by SR-µXRF and Ag LIII-edge SR-µXANES analyses, 
respectively. The measurements were performed using the scanning X-ray microscope of 
beamline ID21, at the European Synchrotron Radiation Facility (ESRF, Grenoble, France), operating 
in a vacuum at room temperature. Details on the instrumental parameters are provided 
elsewere.42 Whole-profile SR-μXRF imaging of Ag was performed in fluorescence mode with 3.42 
keV of excitation energy, with a step (pixel) size of 2 µm and integration time of 100 ms, whereas 
localized maps of regions of interest were obtained at 3 to 0.5 µm pixel size. Other elements 
including P, S and Cl were also determined in all analyses to obtain structural information on the 
specimens. The raw data (counts) were elaborated using the software PyMca 4.7 (ESRF) as 
reported elsewhere42 with some modifications. The SR-μXRF maps also provided a reference for 
spot selection of points of interest to collect Ag LIII-edge SR-µXANES spectra in the 3.32 to 3.42 
keV energy range with 0.5 eV steps. The spectra were elaborated and finally treated by linear 
combination fitting (LCF) using the software Athena 0.9.24 as reported elsewhere.42 Solid-state 
reference compounds used as input variables included: metallic Ag foil, AgCl, Ag2SO4, AgNO3, 
Ag2O, Ag sulfadiazine and a fragment of intact Acticoat Flex3TM dressing. Reference standards of 
metallic AgNPs of 10 nm nominal size, as citrate-stabilized water suspensions, were purchased 
from Sigma-Aldrich (Milan, Italy) and characterized for size distribution and colloidal stability as 
reported elsewhere.42 A standard of Ag bonded to glutathione (GSH) was prepared by incubating 
ionic Ag in an aqueous solution of reduced L-glutathione (Sigma-Aldrich, Milan, Italy) at 37 °C 
under gentle shaking for 2h and in dark conditions, and freeze dried.
2.5 Laser ablation ICP-MS
The semi-quantitative distribution of Ag in the skin profiles of patients B-D was determined by LA-
ICP-MS imaging analysis. The samples from patient B were analysed at the University of Aberdeen 
using a New Wave 213 UP system (Fremont, CA, USA) equipped with a standard cell and coupled 
to an ICP-MS model 7500c from Agilent Technologies (Tokyo, Japan). The samples from patients 
C and D were analysed at Ca’ Foscari University of Venice using a LSX-213 G2+ system (Teledyne 
CETAC Technologies, Omaha, Nebraska, USA), equipped with a solid-state laser based on a YAG 
crystal doped with Nd (Nd:Y3Al5O12) and a HelEx™ two-volume cell, coupled to an ICP-MS model 
7500cx from Agilent Technologies (Tokyo, Japan). All analyses were carried out in scan line mode 
with instrumental parameters optimized for a complete ablation of the tissue. The lateral 
resolution ranged between 4 and 24 µm, and the vertical resolution between 12 and 100 µm, 
depending on the map. Silver was measured by monitoring both m/z 107 and 109 (as an internal 
consistency check), but final elaborations were based on the former mass. Carbon (m/z 13) and P 
(m/z 31) were also measured in all analyses to get structural information on the specimens, while 
Zn (m/z 67) was measured to investigate possible correlation with Ag dynamics. The raw data 
(counts) were elaborated using the software PyMca. Low-resolution quantitative determination 
of the Ag content in the same samples collected from patient B was performed as reported 
elsewhere.22 Briefly, the residual samples after cryosectioning were cut manually using a scalpel, 
digested overnight in an alkaline tetramethylammonium hydroxide solution at 60 °C, diluted in 
Triton X-100 0.1% vol. and NH4OH 2.8% vol. aqueous solutions, and analysed using the Agilent 
















































































































7500cx ICP-MS. High-resolution semi-quantitative concentration profiles for patient B were then 
calculated assuming that the mass-weighted average concentration of the low-resolution profiles, 
was representative of (coincided with) the total concentration in the corresponding slice analysed 
by LA-ICP-MS. The average median signal intensity along the whole profile was calculated and 
represented against the corresponding known bulk concentration of Ag to obtain a calibration 
curve (Supplementary Fig. S1), then used to convert the distribution statistics of signal intensity 
into a mass concentration. Statistica 10 (Statsoft) and Office Excel 365 (Microsoft Corporation) 
were used for data elaboration and graphical works.
3 Results
3.1 Characterization of the dressing and release of Ag in vitro
According to the producer, Acticoat Flex3TM consists of polyester fibres coated with 
nanocrystalline Ag. From a previous characterization by scanning electron microscopy - energy 
dispersive X-ray spectroscopy (SEM-EDX)43 (see also Supplementary Fig. S2A-C), the fibres are ~16 
µm wide and homogeneously coated by a 1.6±0.3 µm thick layer of uncapped unoxidized metallic 
Ag with nanostructured features approximatively of 20 to 170 nm in size. To establish if the 
features are due to nano-roughness of a solid layer or weakly bound particles/agglomerates, the 
dressing was sonicated in water at pH 6 and 7, and analysed by DLS. As shown in Fig. S3, primary 
particles with a mean size of 14±3 nm were observed, in the form of a moderately polydisperse 
(polydispersity index -PDI- <0.4) and moderately stable (ζ-potential <-30 mV) suspension. At pH 5, 
partial oxidative dissolution leaded to size reduction (mean 10±3 nm) and increased colloidal 
stability (ζ-potential ~-43 mV).
The dressing was incubated in standard HSS, containing human serum albumin (HSA), transferrin 
(HTF) and recombinant insulin (HINS) in Iscove’s Modified Dulbecco's Medium. As shown in Fig. 1, 
MALDI-TOF-MS spectra of the soluble Ag fraction revealed that HSA and HTF were bound 
respectively to 1 and 2 atoms of Ag per mole of protein (no mass shift was noticed for HINS, not 
shown). The final concentration of soluble Ag measured by ICP-MS was 0.98±0.03 mM, in good 
correspondence with the saturation of HSA (0.78 mM) and HTF (0.03 mM) given the found 
stoichiometry. The overall depletion of the coating after 3-days of static in vitro migration is 
minimal; most of the coating keeps attached to the fibers and residual detached agglomerates are 
still present in the medium, preserving the original nanostructured surface (Fig. S2C).
3.2 Spatiotemporal and structural distribution of Ag in vivo during a single application
Patient A was treated with a single application of the dressing until complete healing (12 days), 
allowing us to investigate the kinetics of Ag distribution in the healing wound. The samples were 
analysed by SR-µXRF to achieve a complementary detailed structural characterization of the 
specimen.
Before the first application of the dressing, the wound of patient A exhibited complete destruction 
of superficial skin layers (epidermis is absent), and thermal damage to the full thickness of the 
dermis (Fig. 2A and Supplementary Fig. S4A). This structure is typical of inflammation, the first 
















































































































phase of wound healing, consisting in the formation of fibrin cloth and the massive release of 
signalling molecules for immune cells recruitment.46 No Ag signal was observed in the whole 
profile of the skin by SR-µXRF (Supplementary Fig. S4C), supporting the absence of significant 
background levels or contamination of the sample.
After 3 days of treatment, the wound of patient A presented patchy missing and regenerating 
epidermis, and histological features typical of the proliferative phase (second phase of wound 
healing),46 as shown in Fig. 3A, B. Where present, the stratified structure of the epidermis is well 
discernible from the distribution of P, S, and Cl (Fig. 3C, D). The high level of S in the surface layer 
(stratum corneum) is representative of the local accumulation of keratine, an insoluble fibrous 
protein with high proportion of the S-containing amino acid cysteine.47 The distribution of P 
correlates with the cellular density (as a component of membrane phospholipids) and metabolic 
activity (from mitochondrial adenosine triphosphate -ATP- metabolism), both higher in the basal 
layer of the epidermis (stratum basale),48 where proliferating cells provide new tissue for 
reconstruction of the upper layers.49 Wide areas of highly vascularized granulation tissue, 
including islands of squamous epithelium, extend from the epidermis down to the deep dermis 
(reticular dermis). The granulation tissue forms during the proliferative phase of wound healing 
by an intensive and loosely organized production of new extracellular matrix (ECM), a network of 
glycoproteins, collagen and elastin fibres, that provides structural support to the dermal layer.46 
Below the granulation tissue, the reticular dermis presents as an organized and more dense 
structure of connective fibres, where Cl shows its highest concentration.48,50 Hypodermis (large 
fat reservoirs crossed by connective fibres), can be observed at the bottom of the profile. Silver 
was present in significant levels with specific localization in the granulation tissue. The metal did 
not permeate the regenerating epidermis, the reticular dermis, and the underlying hypodermis. 
The zoom map in Fig. 3E shows that Ag formed irregular clusters in the granulation tissue at the 
edge of squamous epithelium, without penetrating it.
Six days after application of the dressing, the wound of patient A was still presenting middle areas 
that lacked the epidermal layer and was covered by an extended scab, as can be seen in Fig. 2B 
and in Fig. 4A-C. The histopathology and elemental maps of the skin profile (Fig. 4A and 
Supplementary Fig. S5A-C), are similar to the 3 days sample (Fig. 3A, C), with granulation tissue 
transitioning toward the deep dermis and an increasing density of connective fibres along the 
depth profile. The scab had the highest local level of Ag detected in all samples from this patient 
(Fig. 4D-F and Supplementary Fig. S5D) and was selected for further speciation analysis by SR-
µXANES (see next section), but the metal was undetectable in the skin layers below 
(Supplementary Fig. S5C). The sample collected from the wound after 9 days of treatment had 
also very similar structural features and elemental distributions, except for the absence of the 
scab and Ag, correspondingly (Supplementary Fig. S6).
After 12 days, the wound reached complete healing (Fig. 2C) and had a fully structured histological 
profile (Fig. 5A, D). The elemental maps (Fig. 5E, F) show a dense and organized structure of the 
tissues. The epidermis presents a uniformly high level of P along the stratum basale and stratum 
spinosum, and a solid stratum corneum with predominant localization of S and Cl. The dermal 
















































































































layer is also fully structured (Fig. 5B), showing an increasing density and organization of the ECM 
from the upper papillary layer to the deeper reticular layer, well represented by the increase of 
Cl. An arterial vessel is clearly visible in the lower part of the reticular dermis (Fig. 5C), just above 
the spongy hypodermis, with relatively high levels of P and S due to the high cellular density, but 
no significant traces of Ag. Silver was not detected along the whole skin profile, except for an 
individual particle 7 μm in size located in the reticular dermis (Fig. 5G, H, corresponding to the 
SR-µXRF spectrum in Fig. 5I). 
3.3 Semi-quantitative spatiotemporal distribution of Ag in vivo during repeated applications
Patient B was treated with repeated applications of the dressing until complete healing (10 days), 
which is the most used therapeutic approach. Laser ablation ICP-MS analysis was adopted to focus 
the study on the semi-quantitative aspects of Ag accumulation.
The spatiotemporal distribution of Ag, Zn, P and C in the healing wound of patient B, obtained by 
LA-ICP-MS imaging, is shown in Fig. 6A. The maps of P and C enable us to identify the raw structural 
characteristics of the specimen (see also Fig. 7). High levels of C in the lower profile outline the 
location of hypodermis, whose adipose tissue is enriched in triglycerides,51 while P is more 
concentrated in the epidermis and the wall of blood vessels, as observed by SR-µXRF in the profiles 
from patient A. After the first application of the dressing, the penetration of Ag into the tissue was 
extensive and consistent with that observed for patient A, reaching a depth of 1.5 mm into the 
granulation tissue. Repeated applications of new dressings entailed further release and 
accumulation of Ag in the skin, with a progressively patchier distribution along the profile. High 
levels of the metal characterize the papillary dermis even after complete healing. A detailed map 
of the healed wound’s upper profile (Fig. 6B) shows that Ag was not detected in the regenerated 
epidermis, although clusters of the metal persist in the dermis above. Thick deposits of Ag on the 
surface of the stratum corneum confirm that the metal is released from the dressing also over the 
regenerating/intact epidermis, but is unable to penetrate the skin barrier, as previously 
hypothesized from indirect estimations.43
Quantitative analysis by ICP-MS after mineralization of the biopsy residues provided low-
resolution but highly accurate profiles of Ag mass concentration (Fig. 6C), from which average full-
profile levels of 8.4, 3.9 and 6.3 ng mg-1 were obtained for the wound after 3, 7 and 10 days, 
respectively. Silver reached the highest concentration within the first mm of depth, at between 
10 and 31 ng mg-1, corresponding to 0.38-0.75 μg per cm-2 of the dressing. After application of a 
semi-quantitative calibration, the elemental maps of Ag were converted into high-resolution 
concentration profiles, less accurate than bulk levels, but providing information on the relative 
spatial dispersion of Ag at the micrometric scale. The semi-quantitative high-resolution profiles 
(Fig. 6C) are consistent with quantitative data and confirm a considerable lack of homogeneity in 
the metal spatial distribution at the micrometric scale, with regions of accumulation in the 
granulation tissue, where Ag reaches a maximum level of 614 ng mg-1 (3 days profile).
According to the maps in Fig. 6A, Zn exhibits a relatively uniform distribution in the wound before 
treatment, but localized deposits of this metal were detected in the adipose tissue 4 days 
















































































































afterwards. A further and more homogeneous increase in Zn levels in the hypodermis was 
observed after 7 days, accompanied by a slightly higher concentration in the regenerating 
epidermis compared to the dermis. In the healed skin, Zn levels and distribution in the dermis and 
hypodermis reverted to those in the initial stage, but still showing relatively higher levels in the 
epidermis, as previously documented.52
Multiple applications of the dressing were adopted also for patient C, who did not exhibit a 
successful regeneration of the tissues after 15 days of treatment. The imaging data of the 15 days 
profile obtained by LA-ICP-MS (Fig. 7) mark a significant accumulation of Ag in the granulation 
tissue, comparable to that of patient A after 4 days of treatment. In the adipose tissue, oblique 
sections of two blood vessels show characteristic elemental compositions. The vein vessel above 
has an irregular section with thin walls and high levels of P, low levels of Zn, and undetected levels 
of Ag. The lower arterial vessel has significant concentrations of Ag in the internal lamina, 
compared to its absence in the surrounding tissue. Conversely, high levels of P and Zn were 
detected in the thick wall of arterial vessel. 
Differently to the others, patient D underwent emergency treatment with Ag sulfadiazine before 
application of the dressing. The maps of Ag distribution along the skin profiles before the first 
application of the dressing and 5 days after (Supplementary Fig. S7) show penetration and 
distribution of the metal globally comparable to those observed for the other patients during the 
proliferative phase, with a significant increase of surface Ag level after application of the dressing. 
3.4 Semi-quantitative speciation of Ag in vivo
Preliminary SR-µXANES analyses performed on the intact dressing confirmed previous 
observations,22,36,53 whereby AgNPs are released by the dressing into the wound environment 
mainly as aggregates/agglomerates (in terms of molar fraction), whose SR-µXANES spectra are 
more similar to that of Ag0 foil rather than to metallic AgNPs suspended standards.
Based on the high Ag level detected in SR-µXRF maps, regions of the same specimens from patient 
A were selected for SR-µXANES speciation analysis. They included: one spot in the dermis of the 
3 days specimen (marked in Fig. 3E and with the SR-µXRF spectrum in Fig. 3F), and five spots in 
the scab of the 6 days specimen (marked in Fig. 4E, F), the latter drawing a depth transect. The 
corresponding average SR-µXANES spectra are represented in Fig.s 3G and 4G. Other regions 
within the same samples were explored without obtaining sufficient signal for reliable speciation 
analysis. Identification of the Ag species and semi-quantitative estimation of their relative molar 
fraction were achieved by LCF using the spectra of pure standards as reported in the Methods. 
The results (see Fig. 4H and Supplementary Table S1) depict a gradual change of speciation as we 
went deeper into the scab, possibly corresponding to specific spatiotemporal dynamics, whose 
endpoint is represented by the speciation of Ag in the dermis of the 3 days sample. Intact metallic 
AgNPs were detected in the scab tissue accounting for 30% of total Ag in the upper 15 µm, 
decreasing to 16% at 30 µm depth and disappearing at 45 µm. However, the main species of Ag 
on the surface was the chloride complex, starting from 60% of total Ag in the upper 45 µm, 
reaching 73% at 45 µm, then decreasing to 32% at 55 µm to disappear at 500 µm of depth into 
















































































































the dermis. These changes were accompanied by a complementary increase in the Ag-protein 
thiol complexes, which started to be detectable at 30 µm until it became the only identifiable 
species in the dermis (molar fraction 81%). The speciation of Ag in the sixth spot of Fig. 3F was 
comparable to that of the scab surface, showing that micrometric agglomerates of pristine 
metallic NPs can be eventually embedded in deeper layers of the scab, but undergo the same 
transformations of the metal.
4 Discussion
Amongst the Ag-containing wound dressings, Acticoat Flex3TM is one of the most widely used. The 
dressing is intended for use on first to second degree burns and chronic ulcers. It is applied directly 
onto the wound, eventually moistened with drinking water in the absence of exudate and secured 
with a gauze. Even if the antibacterial effect is declared for up to 3 days, direct experience in the 
Burn Center has shown that the application time may be considerably varied to optimize the 
efficacy based on the specific conditions of each wound. 
According to both producer specifications and independent characterization, the dressing consists 
of polymer fibres homogeneously coated by a layer of uncapped unoxidized metallic AgNPs. We 
observed that primary particles in the size range of 10 nm can be potentially released as isolated 
objects and kept relatively stable in a liquid medium, particularly at the slightly acidic pH typical 
of wound fluids. Still, under realistic in vitro conditions they are mainly released as agglomerates 
and in such form undergo surface chemical transformations resulting in final release of Ag(I) 
species, more rapidly than possible deagglomeration of the bulk metallic core.42 These 
mechanisms strongly limit the local mobility of AgNPs, and make dissolution the driver for Ag 
mobility and bioaccessibility into the wound. 
Another important variable in release scenarios is concentration, which could compensate for the 
potentially limited mobility of AgNPs for dynamic reasons. Silver concentration in the intact 
product is high: 119±2 mg g-1 corresponding to 0.822±0.016 mg cm-2.43 A previous study has shown 
that only 7% of the Ag is released as dissolved species from 0.3 g of dressing in a 100-fold larger 
mass of HSS after 72h of static incubation.41 Still, from analysis of the dressing after use in vivo, 
the estimated actual release into the patient’s tissues was considerably higher, ranging from 28% 
to 62% of such a dose.43 Locally, the release is strictly dependent on the characteristics of the 
wound bed, being much higher in presence of serous and purulent exudate.43 The values above 
indicate a minimum dosage of 230 μg cm-2 as Ag administered to the patient, which amounts to 
more than double the maximum concentration applied until now in all studies evaluating the in 
vitro/ex vivo permeation of liquid suspended AgNPs through human or porcine skin (min 0.34, 
max 113 μg cm-2).32–34,53,54 The lack of a realistic reference dosage for such experiments limits their 
comparability. This is also exacerbated by the short exposure times (24h) and the static 
experimental conditions, compromising the reliability of the absolute permeated levels of Ag.
Relative evaluations of the available literature data support the hypothesis of a strong correlation 
between the penetration ability of AgNPs and the level of structural damage to the skin 
barrier,34,53 suggesting extensive translocation of the metal into wounded tissues. In the skin of a 
















































































































real patient, treated with a triplicate application of the AgNPs-containing dressing, we measured 
a maximum concentration of Ag in the range of 10-31 ng mg-1 (0.38-0.75 μg cm-2). These values 
are significantly higher than the maximum levels estimated in vitro for AgNPs (coated with 
polyvinyl pyrrolidone -PVP-) in glycerolized dermis (3.5 ng mg-1),53 but compatible with the in vitro 
penetration of uncapped AgNPs in cryopreserved intact epidermis (mode 1.05 μg cm-2) and dermis 
(mode 0.30 μg cm-2).54 Highly variable total levels of Ag have been previously observed in vivo, in 
healthy (range 6 to 199 ng mg-1 after one application,36 and burnt tissues (range 9.1 to 47.5 ng 
mg-1 after max two applications;22 136±91 ng mg-1 after nine applications40), when the dressing 
was applied to humans or pigs under simulated conditions.
In the present study, it was shown that single-status bulk data are not comparable, because the 
level of Ag in the wound is highly dependent on the time, space (depth), and on the local structural 
characteristics of the tissue.
High-resolution two-dimensional maps of Ag distribution confirmed the previous observations 
from low-resolution depth profiles,22 namely that Ag can significantly penetrate the skin of burn 
patients at the millimetre scale down to the dermis, which is considerably deeper than previous 
observations in vitro/ex vivo for intact or tape-stripped porcine skin (max 22±5 µm).32,33 The 
characteristic spatiotemporal distribution of the metal in the wound tissue suggests an inverse 
association with its level of structural organization, as Ag penetrates rapidly and in depth only into 
the granulation tissue. As the skin regenerates, the metal accumulates in the upper layers of the 
dermis, while its concentration in the deeper layers decreases, supporting an efficient process of 
clearance. Local persistence of Ag was noticed only in patchy accumulation regions, where a 
structured organization of the collagen fibres was still lacking and/or due to the possible 
translocation of the metal from adjacent unhealed zones. On a clinical basis, no interference was 
observed on the process of wound healing after treatment with the AgNPs-containing dressing. 
The distribution pattern of Ag is therefore likely to be a consequence, not a cause of the structural 
characteristics of the tissue. As long as the regeneration proceeds correctly and new epidermis is 
formed, further AgNPs released by the dressing are unable to penetrate the stratum corneum. 
The kinetics of Ag clearance in a regularly healing wound after a single application of the dressing, 
shows that after 12 days the metal is almost quantitatively removed from the skin.
The spatio-temporal distribution of total Ag in the wounded skin provides only partial depicting 
of its dynamics, complemented by biochemical transformations. Several studies have investigated 
the dissolution kinetics of functionalized AgNPs in vitro using a medium whose maximum 
complexity consisted of cell culture media (Dulbecco's Modified Eagle Medium and Hoagland’s 
Modified Medium).14 They showed that organic molecules slow down the process by surface 
passivation, while chloride accelerates it, and helps the formation of secondary particles. Pooled 
with a complementary study recently carried out in vitro,42 the present data on Ag speciation in 
wound tissues suggest an integrated and space/time-dependent process taking place at first on 
the surface of the pristine metallic aggregates of NPs. In contact with the acidic wound fluids Ag+ 
ions are released and rapidly transformed into a crust of insoluble chlorides (kinetically favoured) 
at the agglomerates’ surface, these are then coated by a protein corona. As penetration of AgNPs 
















































































































proceeds into the wound (in time at a daily scale, and in space at the tenth of µm scale), the metal 
is exchanged between chloride and protein thiols that are more thermodynamically favoured 
complexing agents. Protein complexes are the quantitatively dominant form of Ag into the skin 
tissues, and the responsible for mobilization of the metal towards vascular networks, resulting in 
its final removal from the wound. In patient C, who underwent multiple applications of the 
dressing for 15 days without full healing, we observed a significant level of Ag in the wall of an 
arterial vessel, while the metal was absent in the surrounding tissue. This supports an extensive 
systemic mobilization of Ag within the bloodstream, beside local permeation into the wound, 
compatibly with previous quantitative data on Ag levels in the blood of burn patients.42
As argued by simplified in vitro simulations,41 this in vivo observation indicates that serum proteins 
in the contact medium play a central role as the driving factor for the kinetics of a set of 
concatenated processes, including: i) release of Ag from the dressing; ii) dissolution of the 
particles; and iii) mobilization of Ag+ through the skin and the vascular system. In the exudate, and 
other intercellular environments several bioligands may be responsible for Ag binding through R-
SH groups, including HSA, immunoglobulin G,55 GSH56, metallothioneins (MTs)57,58 and HTF, as 
observed here. At the surface of AgNPs, such interactions affect their dissolution rate and 
agglomeration state in protein-specific ways.55 Given the abundance and the colloidal stabilization 
action, HSA is a major candidate for passive carriage of Ag in both nanoparticulate and ionic from. 
Notably, the formation of protein corona and sequestration of Ag+ by thiol groups in the 
extracellular fluids affect the cellular uptake of Ag, impacting its cytotoxicity, and reduce its 
antimicrobial efficacy, as shown against E. coli, P. aeruginosa and S. aureus.56
In any case, the clearance of Ag from the skin of patient A involved in this study required 
dissolution and protein complexation, and is compatible with the absence of AgNPs agglomerates 
in the blood of other burn patients treated with the same dressing.42 Persisting Ag deposits were 
observed in the dermis after repeated applications of the dressing, which were supposed to be 
pristine agglomerates of AgNPs mechanically inserted into the open wound during the first phase 
of treatment, and are sufficiently large to have slower dissolution compared to the surrounding 
regeneration of the tissue.59 This scenario is more probable than formation of secondary particles 
of sulphide/selenide complexes (which have been proposed to occur in the gastrointestinal tract)9 
or photoreduced metallic Ag (since the wound is protected from light), and can also explain the 
localized cellular internalization of AgNPs agglomerates that was previously observed (see also 
Supplementary Fig. S2D-F).22 Still, further investigations are needed to establish the composition 
of Ag species in such residual deposits of the metal. Similar dynamics were observed in the patient 
D pre-treated with Ag sulfadiazine. This supports the hypothesis that both AgNPs and Ag 
sulfadiazine share the same final mechanism of Ag mobilization into the skin through the Ag+ 
complexed ion. The dissolution of AgNPs and further changes in speciation of the metal observed 
during penetration into the wound tissues in vivo, shows that the dynamics of total Ag cannot be 
considered as representative of that of AgNPs. This demonstrates that any quantitative skin 
permeation experiment carried out so far must be considered incomplete without a 
complementary speciation study, and that in vitro experiments are currently far from representing 
reliable simulations of a real wound environment.
















































































































In spite of the rapid clearance of Ag from the skin observed here, the metal can bind several 
ligands other than thiols, such as amino, carboxyl, phosphate and imidazole groups, making it 
prone to interfere with many intracellular systems, including RNA and DNA.57 Particularly in the 
regenerating wound, the interaction of Ag with MTs, beside its own detoxification, may affect 
other key functions that these metalloenzymes play in the modulation of inflammatory response, 
formation of granulation tissue and the epidermal proliferation.57 An altered homeostasis of Zn 
may mirror these effects. In the regenerating wound, Zn plays an important role as a cofactor of 
MTs, stabilizer of cellular membranes and up-regulator of mitotic processes.39,57,61 It may also act 
as a modulator of matrix metalloproteinases (MMPs, proteolytic enzymes responsible for ECM 
degradation and reconstruction, and cell migration modulation),62 and as an up-regulator of 
integrins (responsible for keratinization and keratinocytes migration)63 and Zn-finger transcription 
factors. These actions can explain the increase in intracellular Zn levels observed in the 
regenerating wound, particularly during the early inflammation phase and at the wound 
margins.58,61 Assuming that the distribution of Zn mirrors the activity or the expression of MTs, 
higher levels are expected in the epidermis than in the dermis both in healthy skin61 and in 
regenerating wounds during the proliferative phase (2-5 days in a rat model).62 The elemental 
maps obtained in this study confirm this hypothesis, showing higher levels of Zn in the epidermis 
than in the dermis both during regeneration, and after complete healing. A maximum increase of 
the overall Zn level was observed 7 days after injury, followed by a re-normalization after 10 days. 
However, the maps revealed the highest concentration and increase of Zn in the adipose tissue, 
which has not been documented before. We also observed relatively high levels of Zn in the wall 
of an arterial vessel. The latter may be representative of the role played by Zn in angiogenesis by 
modulating the activity of MMPs, or with normal expression of MTs in vascular endothelial cells,64 
and is compatible with the observed accumulation of Zn in the aorta of a rat model after 
intravenous injection of inorganic Zn.65 An interaction between Ag and Zn should also be 
considered. Some authors suggest that Ag promotes epidermal cell proliferation by increasing the 
uptake of Zn and Cu through induction of MTs synthesis,66 possibly mediated by intracellular ROS 
generation;28 while others state that AgNPs are able to indirectly down-regulate the activity of 
MMPs in the wound,67 resulting in dermal inflammatory cell apoptosis, possibly through the 
displacement of Zn2+ by the Ag+ ion.68 We observed an opposite distribution of the two metals 
during healing. Combined with the dissolution of AgNPs in the exudate and the upper wound 
layers, this supports an interaction between Ag and Zn which is mediated by their ionic forms.
5 Conclusion
Our findings demonstrate that both SR-µXRF and LA-ICP-MS enable two-dimensional imaging of 
Ag (and multielemental) distribution in human tissues, with a comparable sensitivity of 200 cps 
μm-2 per pg mg-1 of the metal. Synchrotron radiation-µXRF has a fixed spatial resolution 
determined by the size of the beam at the specific beamline (usually ≈1 x 0.5 µm at ID21), and is 
non-destructive, being perfectly suited to compare the distribution of Ag with the structural 
characteristics of the biological tissue. It also allows to perform point-specific speciation analysis 
of Ag by SR-µXANES, at the same micrometre scale. Still, LA-ICP-MS instruments have tunable 
beam size (from 5 to 200 µm for those used in this work), and high power, to improve the absolute 
















































































































detection limit for Ag well below the level of ng mg-1, over larger scanned areas. The advantages 
of these techniques were combined to achieve the first direct observation of the biochemical 
dynamics of Ag into full-profile specimens of wounded skin from four patients, treated with the 
dressing Acticoat Flex3TM. Rapid release and accumulation of Ag onto the wound bed, and 
millimetre-scale penetration of the metal into the damaged tissues, were observed. Still, 
speciation data proved that, in vivo and in real patients, AgNPs get rapidly dissolved in situ before 
reaching the systemic distribution, while extensive mobilization of Ag involves its bio-complexed 
ionic species. These data support the capability of the dressing to exert an intense bioactive action 
focused onto the surface layer of the wound. Further applications of this experimental approach 
to a wider number and variety of patients, wounds, samples and dressings will be important to 
strengthen the representativity of present results in realistic clinical scenarios. Questions remain 
open on the effects of possible functionalization of AgNPs in alternative dressing designs, the 
biochemical mechanisms and clinical relevance of possible toxic effects leaded by the metal during 
its residence time into the wound, the mechanisms of potential interaction with Zn, and the fate 
of Ag after entering systemic circulation.
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Figure 1. MALDI-TOF-MS spectra of selected m/z windows showing the peaks of HSA (A) and HTF 
(B) in HSS after 72h of static incubation of the AgNPs-containing dressing (black line), and 
corresponding control medium (gray line). The mass shifts corresponding to bounded Ag ions are 
indicated.
















































































































Figure 2. Pictures of the wound of patient A before application of the AgNP-containing dressing 
(A) and after 6 (B) and 12 (C) days of treatment. The arrows indicate: *dressing; **wound margin; 
***scab; ****healed skin.
















































































































Figure 3. Full profile biopsy specimen of the wound of patient A, 3 days after a single application 
of the AgNP-containing dressing, analysed by SR-μXRF and SR-XANES. (A) Histological image of the 
tissue (adjacent slice). (B) Picture of the analysed slice. The scanned area locates in the white 
frame. (C) Maps of signal intensities (cps) of Ag (log scale), P, S and Cl (linear scales); pixel size 2 
µm. (D) Ternary RGB plot of the same elemental maps. The arrows indicate: *stratum corneum; 
**stratum spinosum; ***stratum basale; ****fragments of epidermis extending in the 
granulation tissue; #granulation tissue; +reticular dermis; ohypodermis. (E) zoom RGB map of the 
region located in the frame (independent acquisition, pixel size 2 µm), the arrow indicates the 
region selected for SR-μXANES analysis; (F) average SR-µXRF spectrum of the whole zoom map 
area; (G) average SR-µXANES spectrum in the selected region (dotted line) overlapped to its best 
LCF function (solid line).
















































































































Figure 4. SR-µXRF elemental imaging and spectral data of the skin profile from patient A 6 days 
after application of the AgNP-containing dressing. (A) histological image of the tissue (adjacent 
slice) and (B) zoom of the scab region; (C) image of the analysed slice, the upper portion of the 
scanned area locates in the white frame (for the whole scanned area see Supplementary Fig. S2); 
(D) map of signal intensity of Ag (cps, logarithmic scale, pixel size 2 µm), the white frames locate 
the areas selected for independent zoom scans (E) and (F), in which the spots chosen for SR-
µXANES analysis are indicated. (G) SR-µXANES spectra of the selected spots (dotted lines) 
overlapped to their best LCF function (solid lines); (H) Ag speciation as function of the depth along 
the skin tissue profile, the molar fraction of distinct species was estimated by LCF of the SR-
µXANES spectra and are reported in Supplementary Table S1.
















































































































Figure 5. Full profile biopsy specimen of the wound of Patient A, 12 days after a single application 
of the AgNP-containing dressing (complete healing), analysed by SR-μXRF. (A) Histological image 
of the tissue (adjacent slice), with zoom images of the regenerated epidermis (B) and an arterial 
blood vessel (C). (D) Picture of the analysed slice. The scanned area locates in the white frame. (E) 
Maps of signal intensities (cps) for Ag (logarithmic scale), P, S and Cl (linear scale); pixel size 2 µm. 
(F) Ternary RGB plot of the same elemental maps. The symbols indicate: *epidermis; **papillary 
dermis; ***reticular dermis; ****hypodermis; #arterial vessel. (G) and (H): two consecutive zoom 
maps of the region located in the white frame, independent acquisitions with pixel size 1 µm and 
0.5 µm, respectively. (I) Average µXRF spectrum of the whole zoom map area h.
















































































































Figure 6. Full profile biopsy specimen of the wound of patient B, before (Day 0) and after repeated 
applications of the AgNP-containing dressing (Day 4 - 1st app.; Day 7 – 2nd app.; Day 10 = 3rd app., 
complete healing), analysed by LA-ICP-MS. (A) Maps of signal intensities (cps) for Ag, Zn, P and C 
(linear scales); pixel size 24 x 100 µm. (B) Detailed map of Ag and P distribution in the surface 
region of a slice adjacent to the one shown in A)-day 10, pixel size 4 x 12 µm. The arrows indicate: 
*stratum corneum; **stratum granulosum; ***stratum spinosum; ****stratum basale; #papillary 
dermis. (C) Depth profiles of Ag concentration in the same samples: the dots are quantitative data 
(average ± σ) obtained by mineralization and ICP-MS analysis of biopsy residues. Curves are semi-
quantitative estimations obtained from the imaging data in a): median (dark line), interquartile 
range (grey band) and maximum value of the lateral distribution (vertical resolution 14 μm).
















































































































Figure 7. Maps of Ag, Zn, P and C distribution in the skin profile from patient C after 15 days of 
treatment with repeated applications of the AgNP-containing dressing. Data obtained by LA-ICP-
MS with pixel size 24 x 30 µm; signal intensity in cps with linear scale. The arrows indicate: *vein; 
**artery.















































































































Table of contents entry: highlights
First observation of AgNPs dynamics in the wounds of real patients through elemental imaging and 
speciation
















































































































Page 29 of 29 Analyst
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
A
na
ly
st
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
is
he
d 
on
 2
7 
A
ug
us
t 2
02
0.
 D
ow
nl
oa
de
d 
on
 8
/3
0/
20
20
 1
:4
3:
52
 A
M
. 
View Article Online
DOI: 10.1039/D0AN00607F
